




Searching News Database: PNH
HSMN NewsFeed - 15 Oct 2021
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
HSMN NewsFeed - 13 Sep 2013
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
Alexion's Soliris(R) (eculizumab) Receives Marketing Approval in Japan for All Patients with aHUS
HSMN NewsFeed - 29 Sep 2010
Quidel Announces FDA Clearance of Its QuickVue(R) RSV 10 Immunoassay Diagnostic Test
Quidel Announces FDA Clearance of Its QuickVue(R) RSV 10 Immunoassay Diagnostic Test
HSMN NewsFeed - 1 Apr 2009
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
HSMN NewsFeed - 10 Dec 2007
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
HSMN NewsFeed - 20 Aug 2007
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
HSMN NewsFeed - 22 Jun 2007
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Alexion's Soliris(TM) Granted Marketing Approval in Europe for Treatment of All Patients With PNH
HSMN NewsFeed - 11 Jun 2007
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
Studies Show Efficacy and Safety of Alexion's Soliris(TM) in Broad Population of PNH Patients
HSMN NewsFeed - 4 Jun 2007
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
HSMN NewsFeed - 13 Jul 2006
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
HSMN NewsFeed - 16 Jun 2006
Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Announces the EXPLORE Clinical Diagnostic Study for Paroxysmal Nocturnal Hemoglobinuria (PNH)
HSMN NewsFeed - 13 Mar 2006
Alexion Updates Previously Announced Phase III Results for PRIMO-CABG2 Study
Alexion Updates Previously Announced Phase III Results for PRIMO-CABG2 Study
Additional items found! 21

Members Archive contains
21 additional stories matching:
PNH
(Password required)
PNH
(Password required)